SpazioTennis

DOPING ERRANI, L’ITF UFFICIALIZZA UNA SQUALIFICA DI DUE MESI

È arrivata la decisione ufficiale da parte delle autorità della Federazione Internazionale di Tennis (ITF) in merito al caso Errani esploso questa mattina.

La tennista bolognese è stata infatti trovata positiva ad un controllo antidoping effettuato ad inizio stagione; come riportato dal Corriere della Sera, nelle urine della campionessa, sarebbero state trovate tracce di arimidex, riconducibile a un principio attivo farmacologico appartenente alla classe S4 degli stimolatori ormonali e metabolici (clicca QUI per la storia completa).

Dal comunicato ufficiale apparso sul sito della ITF si è appreso che Sara Errani ha assunto la sostanza involontariamente mangiando i tortellini in brodo preparati dalla madre, la quale assume un farmaco anti-tumorale chiamato “Femara”. La tennista n.98 del ranking ha ammesso l’assunzione della sostanza nel mese di Aprile, e dopo un’udienza andata in scena nel mese di Luglio a Londra la Federazione ha deciso di annullare tutti i risultati ottenuti dall’italiana tra il 16 febbraio e il 7 giugno.

Sarita dovrà adesso scontare un periodo di stop forzato che va dal 3 agosto alla mezzanotte del 2 ottobre, prima di tornare all’attività professionistica.


RIPORTIAMO DI SEGUITO IL COMUNICATO UFFICIALE RILASCIATO DALL’ITF


7 August 2017 – London, ENGLAND – An Independent Tribunal appointed under Article 8.1 of the 2017 Tennis Anti-Doping Programme (the “Programme”) has found that Sara Errani committed an Anti-Doping Rule Violation under Article 2.1 of the Programme and, as a consequence, has disqualified the affected results and imposed a period of ineligibility of two months, commencing on 3 August 2017.

Ms. Errani, a 29-year-old player from Italy, provided a urine sample on 16 February 2017 as part of an Out-of-Competition test under the Programme. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain letrozole, which is an aromatase inhibitor that is included under section S4 (Hormone and Metabolic Modulators) of the 2017 WADA Prohibited List, and therefore is also prohibited under the Programme.

On 18 April 2017, Ms. Errani was charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player’s Sample). She promptly admitted that she had committed the Anti-Doping Rule Violation charged, and asked for a hearing before an Independent Tribunal in accordance with Article 8 of the Programme to determine the consequences to be imposed on her for that violation.

At a hearing on 19 July 2017, the Independent Tribunal received evidence and heard legal arguments from both parties, and subsequently issued a reasoned decision on 3 August, which is available below. The Independent Tribunal determined that (1) Ms. Errani should serve a period of ineligibility of two months, beginning on 3 August and so ending at midnight on 2 October 2017; and (2) her results between 16 February 2017 (the date of sample collection) and 7 June 2017 (and the date of her next test, which was negative) should be disqualified, with resulting forfeiture of the ranking points and prize money that she won at events during that period.

The Tennis Anti-Doping Programme applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed under the Programme in compliance with the requirements of the World Anti-Doping Code. More information on the Programme, sanctions, statistics, and related matters can be found at www.itftennis.com/antidoping.

Read more at http://www.itftennis.com/news/267585.aspx#IKklMUs1JwKHEjUz.99

Commenta

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *